LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| BT-20 | Momelotinib | 0.2982 |
| BT-20 | Dasatinib | 0.8755 |
| BT-20 | Dovitinib | 0.5738 |
| BT-20 | Enzastaurin | -0.0904 |
| BT-20 | Erlotinib | 0.1661 |
| BT-20 | Alvocidib | 1.1891 |
| BT-20 | Foretinib | 0.6967 |
| BT-20 | Pictilisib | 0.6248 |
| BT-20 | GDC-0980 | 1.0410 |
| BT-20 | Gefitinib | 0.0782 |
| BT-20 | Geldanamycin | 1.0228 |
| BT-20 | GSK 690693 | 0.3945 |
| BT-20 | GSK1059615 | 0.8931 |
| BT-20 | GSK1904529A | 0.0734 |
| BT-20 | Omipalisib | 1.2231 |
| BT-20 | GW843682X | 0.7556 |
| BT-20 | HG-5-113-01 | 0.4048 |
| BT-20 | HG-5-88-01 | 0.1624 |
| BT-20 | HG-6-64-01 | 0.3550 |
| BT-20 | Imatinib | -0.0069 |
| BT-20 | JNK-9L | 0.6159 |
| BT-20 | JW-7-24-1 | 0.2993 |
| BT-20 | KIN001-043 | 0.0871 |
| BT-20 | Lapatinib | 0.0664 |
| BT-20 | LDN-193189 | 0.4508 |